Kamola Anvarjon kizi Almirzayeva

2 ta ish

Tashkent Pharmaceutical Institute, Tashkent, Republic of Uzbekistan

1. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

   Kamola Anvarjon kizi Almirzayeva

   MaqolaChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.020463

2. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

   Kamola Anvarjon kizi Almirzayeva

   MaqolaChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.020637